A systems biology approach to characterize biomarkers for blood stasis syndrome of unstable angina patients by integrating MicroRNA and messenger RNA expression profiling

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Jie ^a   Yu, Gui ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; E1A ASSOCIATED P300 PROTEIN; HISTONE DEACETYLASE 1; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN KINASE B; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; BLOOD STASIS SYNDROME; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMS BIOLOGY; UNSTABLE ANGINA PECTORIS; UPREGULATION;

EID: 84878688708     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/510208     Document Type: Article

References (111)

1. Wright R. S., Anderson J. L., Adams C. D., Bridges C. R., Casey D. E., Ettinger S. M., Fesmire F. M., Ganiats T. G., Jneid H., Lincoff A. M., Peterson E. D., Philippides G. J., Theroux P., Wenger N. K., Zidar J. P., 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/ Non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011 123 18 2022 2060
2. Braunwald E., Unstable angina and non-ST elevation myocardial infarction. American Journal of Respiratory and Critical Care Medicine 2012 185 9 924 932 10.1164/rccm.201109-1745CI
3. Kuzniatsova N., Shantsila E., Blann A., Lip G. Y. H., A contemporary viewpoint on 'aspirin resistance'. Annals of Medicine 2012 44 8 773 783 10.3109/07853890.2011.605388
4. Golomb B. A., Evans M. A., Dimsdale J. E., White H. L., Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Archives of Internal Medicine 2012 172 15 1180 1182
5. Zhang Y. C., Lu B. J., Zhao M. H., Rong Y. Z., Chen R. M., Effect of Shengmai injection on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus. Chinese Journal of Integrative Medicine 2008 14 4 281 285 2-s2.0-57749179523 10.1007/s11655-008- 0281-3
6. Qin F., Huang X., Guanxin II for the management of coronary heart disease. Chinese Journal of Integrative Medicine 2009 15 6 472 476 2-s2.0-73849148814 10.1007/s11655-009-0472-6
7. Jiang Y. R., Miao Y., Yang L., Effect of chinese herbal drug-containing serum for activating-blood and dispelling-toxin on ox-LDL-induced inflammatory factors' expression in endothelial cells. Chinese Journal of Integrative Medicine 2012 18 1 30 33 10.1007/s11655-011-0849-1
8. Liu H. Y., Wang W., Shi D. Z., Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention. Chinese Journal of Integrative Medicine 2012 18 6 423 430 10.1007/s11655-012-0966-5
9. Xue M., Yin H. J., Wu C. F., Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome. Chinese Journal of Integrative Medicine 2013 19 1 42 47 10.1007/s11655-011-0604- 7
10. Zhang J. H., Shang H. C., Gao X. M., Zhang B. L., Xiang Y. Z., Cao H. B., Ren M., Wang H., Compound salvia droplet pill, a traditional Chinese medicine, for the treatment of unstable angina pectoris: a systematic review. Medical Science Monitor 2008 14 1 RA1 RA7 2-s2.0-38149044266
11. Qiu X., Miles A., Jiang X., Sun X., Yang N., Sulfotanshinone sodium injection for unstable angina pectoris: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 17 203043 10.1155/2012/715790
12. Ferreira A. S., Lopes A. J., Chinese medicine pattern differentiation and its implications for clinical practice. Chinese Journal of Integrative Medicine 2011 17 11 818 823 10.1007/s11655-011-0892-y
13. Lu A. P., Bian Z. X., Chen K. J., Bridging the traditional Chinese medicine pattern classification and biomedical disease diagnosis with systems biology. Chinese Journal of Integrative Medicine 2012 18 12 883 890 10.1007/s11655-012-1290-6
14. Lu A. P., Chen K. J., Chinese medicine pattern diagnosis could lead to innovation in medical sciences. Chinese Journal of Integrative Medicine 2011 17 11 811 817 10.1007/s11655-011-0891-z
15. Yao K. W., He Q. Y., Teng F., Logistic regression analysis of syndrome essential factors in patients with unstable angina pectoris. Journal of Traditional Chinese Medicine 2011 31 4 273 276 10.1016/S0254-6272(12)60003-X
16. Chen K. J., Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chinese Journal of Integrative Medicine 2012 18 12 891 896 10.1007/s11655-012-1291-5
17. Liu Y., Yin H. J., Shi D., Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies. Evidence-Based Complementary and Alternative Medicine 2012 2012 8 10.1155/2012/184503 184503
18. Xue M., Chen K. J., Yin H. J., Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome. Chinese Journal of Integrative Medicine 2008 14 4 267 273 2-s2.0-57749168386 10.1007/s11655-008-0267-1
19. Feng Y., Xu H., Qu D., Zheng F., Shi D. Z., Chen K. J., Study on the tongue manifestations for the blood-stasis and toxin syndrome in the stable patients of coronary heart disease. Chinese Journal of Integrative Medicine 2011 17 5 333 338 2-s2.0-79960124721 10.1007/s11655-011-0615-4
20. Liu Y., Yin H. J., Chen K. J., Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease. Chinese Journal of Integrative Medicine 2011 17 8 587 592 10.1007/s11655-011-0814-z
21. Yao K. W., Chu F. Y., Wang J., A clinical epidemiological study of the quantitative diagnosis scale of blood stasis syndrome. Chinese Journal of Integrative Medicine 2011 17 3 200 204 2-s2.0-79952569176 10.1007/s11655-011- 0667-5
22. Wang J., Chen K. J., Weng W. L., Study on the diagnostic criteria of blood stasis syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 1988 8 10 585 589
23. Chu F. Y., Wang J., Yao K. W., Li Z. Z., Effect of Xuefu Zhuyu Capsule on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: a randomized controlled trial. Chinese Journal of Integrative Medicine 2010 16 5 399 405 2-s2.0-79952278606 10.1007/s11655-010-9999-9
24. Liu Y. F., Yu H. M., Zhang C., Yang R. X., Yan F. F., Liu Y., Zhang Y., Zhao Y. X., Effects of Quyu xiaoban capsules on clinical outcomes and platelet activation and aggregation in patients with unstable angina pectoris. Journal of Alternative and Complementary Medicine 2007 13 5 571 576 2-s2.0-34347362948 10.1089/acm.2007.6226 (Pubitemid 47015342)
25. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
26. van Rooij E., Olson E. N., MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature Reviews Drug Discovery 2012 11 11 860 872 10.1038/nrd3864
27. Creemers E. E., Tijsen A. J., Pinto Y. M., Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation Research 2012 110 3 483 495 10.1161/CIRCRESAHA.111.247452
28. de Hoon M. J. L., Imoto S., Nolan J., Miyano S., Open source clustering software. Bioinformatics 2004 20 9 1453 1454 2-s2.0-3142756502 10.1093/bioinformatics/bth078 (Pubitemid 38931415)
29. Saldanha A. J., Java treeview-extensible visualization of microarray data. Bioinformatics 2004 20 17 3246 3248 2-s2.0-9444225935 10.1093/ bioinformatics/bth349 (Pubitemid 39619217)
30. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
31. Kanehisa M., Goto S., Sato Y., Furumichi M., Tanabe M., KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research 2012 40 1 D109 D114 10.1093/nar/gkr988
32. Maragkakis M., Reczko M., Simossis V. A., Alexiou P., Papadopoulos G. L., Dalamagas T., Giannopoulos G., Goumas G., Koukis E., Kourtis K., Vergoulis T., Koziris N., Sellis T., Tsanakas P., Hatzigeorgiou A. G., DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Research 2009 37 2 W273 W276 2-s2.0-67650747402 10.1093/nar/gkp292
33. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 1 15 20 2-s2.0-11844278458 10.1016/j.cell.2004.12.035 (Pubitemid 40094598)
34. Laczny C., Leidinger P., Haas J., miRTrail-a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases. BMC Bioinformatics 2012 12 1 36
35. Kuentzer J., Blum T., Gerasch A., BN++-a biological information system. Journal of Integrative Bioinformatics 2006 3 2 34
36. de Las Rivas J., Fontanillo C., Protein-protein interaction networks: unraveling the wiring of molecular machines within the cell. Briefings in Functional Genomics 2012 11 6 489 496 10.1093/bfgp/els036
37. Wu G., Feng X., Stein L., A human functional protein interaction network and its application to cancer data analysis. Genome Biology 2010 11 5, article R53 2-s2.0-77952310528 10.1186/gb-2010-11-5-r53
38. Smoot M. E., Ono K., Ruscheinski J., Wang P., Ideker T., Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011 27 3 431 432 10.1093/bioinformatics/btq675
39. Barabási A. L., Oltvai Z. N., Network biology: understanding the cell's functional organization. Nature Reviews Genetics 2004 5 2 101 113 2-s2.0-0742305866 10.1038/nrg1272 (Pubitemid 38160277)
40. Lin C. Y., Chin C. H., Wu H. H., Chen S. H., Ho C. W., Ko M. T., Hubba: hub objects analyzer-a framework of interactome hubs identification for network biology. Nucleic Acids Research 2008 36 W438 W443 2-s2.0-48449102450 10.1093/nar/gkn257
41. Nolan T., Hands R. E., Bustin S. A., Quantification of mRNA using real-time RT-PCR. Nature Protocols 2006 1 3 1559 1582 2-s2.0-33847643776 10.1038/nprot.2006.236
42. Inohara N., del Peso L., Koseki T., Chen S., Núñez G., RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. Journal of Biological Chemistry 1998 273 20 12296 12300 2-s2.0-0032524908 10.1074/jbc.273.20.12296 (Pubitemid 28240597)
43. Geng Y. J., Libby P., Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 β -converting enzyme. The American Journal of Pathology 1995 147 2 251 266 2-s2.0-0029115152
44. Chen F., Eriksson P., Kimura T., Herzfeld I., Valen G., Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque. Coronary Artery Disease 2005 16 3 191 197 2-s2.0-17844365563 10.1097/00019501-200505000-00009 (Pubitemid 40586202)
45. Clarke M. C. H., Figg N., Maguire J. J., Davenport A. P., Goddard M., Littlewood T. D., Bennett M. R., Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nature Medicine 2006 12 9 1075 1080 2-s2.0-33748469506 10.1038/nm1459 (Pubitemid 44353389)
46. Tabas I., Macrophage death and defective inflammation resolution in atherosclerosis. Nature Reviews Immunology 2010 10 1 36 46 2-s2.0-72949116358 10.1038/nri2675
47. Fan T. J., Han L. H., Cong R. S., Liang J., Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 2005 37 11 719 727 2-s2.0-33644812102 10.1111/j.1745-7270.2005.00108.x (Pubitemid 44890981)
48. Magalhaes J. G., Lee J., Geddes K., Rubino S., Philpott D. J., Girardin S. E., Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. European Journal of Immunology 2011 41 5 1445 1455 2-s2.0-79955129532 10.1002/eji.201040827
49. Huo Y., Weber C., Forlow S. B., Sperandio M., Thatte J., Mack M., Jung S., Littman D. R., Ley K., The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. Journal of Clinical Investigation 2001 108 9 1307 1314 2-s2.0-0035189760 10.1172/JCI200112877 (Pubitemid 33107758)
50. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., Asano M., Moriwaki H., Seishima M., Lack of interleukin-1ß decreases the severity of atherosclerosis in apoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 656 660 2-s2.0-0037388984 10.1161/01.ATV.0000064374. 15232.C3 (Pubitemid 36438080)
51. Qamar A., Rader D. J., Effect of interleukin 1 β inhibition in cardiovascular disease. Current Opinion in Lipidology 2012 23 6 548 553 10.1097/MOL.0b013e328359b0a6
52. Ozeren A., Aydin M., Tokac M., Demircan N., Unalacak M., Gurel A., Yazici M., Levels of serum IL-1 β IL-2, IL-8 and tumor necrosis factor- α in patients with unstable angina pectoris. Mediators of Inflammation 2003 12 6 361 365 2-s2.0-0742321794 10.1080/09629350310001633360 (Pubitemid 38161144)
53. Simon A. D., Yazdani S., Wang W., Schwartz A., Rabbani L. E., Circulating levels of IL-1 β a prothrombotic cytokine, are elevated in unstable angina versus stable angina. Journal of Thrombosis and Thrombolysis 2000 9 3 217 222 2-s2.0-0034035895 (Pubitemid 30201252)
54. Libby P., What have we learned about the biology of atherosclerosis? The role of inflammation. American Journal of Cardiology 2001 88 7 3J 6J 2-s2.0-0035845994 (Pubitemid 32938245)
55. Alexander M. R., Moehle C. W., Johnson J. L., Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. The Journal of Clinical Investigation 2012 122 1 70 79 10.1172/JCI43713
56. Janssens S., Beyaert R., Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Molecular Cell 2003 11 2 293 302 2-s2.0-0037292275 10.1016/S1097-2765(03)00053-4 (Pubitemid 36293825)
57. Hulsmans M., Geeraert B., de Keyzer D., Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One 2012 7 1 e30414
58. Skalhegg B. S., Tasken K., Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Frontiers in Bioscience 2000 5 D678 D693 2-s2.0-0034241380
59. Deveraux Q. L., Reed J. C., IAP family proteins-suppressors of apoptosis. Genes and Development 1999 13 3 239 252 2-s2.0-0033082995 (Pubitemid 29095796)
60. Kutuk O., Basaga H., Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis. Apoptosis 2006 11 10 1661 1675 2-s2.0-33748573684 10.1007/s10495-006-9402-7 (Pubitemid 44371045)
61. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T. B., Oukka M., Kuchroo V. K., IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells. Nature 2007 448 7152 484 487 2-s2.0-34547232503 10.1038/nature05970 (Pubitemid 47123515)
62. Zlotnik A., Yoshie O., Chemokines: a new classification system and their role in immunity. Immunity 2000 12 2 121 127 2-s2.0-0034144269 (Pubitemid 30398626)
63. Hesselgesser J., Ng H. P., Liang M., Zheng W., May K., Bauman J. G., Monahan S., Islam I., Wei G. P., Ghannam A., Taub D. D., Rosser M., Snider R. M., Morrissey M. M., Perez H. D., Horuk R., Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. Journal of Biological Chemistry 1998 273 25 15687 15692 2-s2.0-14444283367 10.1074/jbc.273.25.15687 (Pubitemid 28298186)
64. Valenzuela-Fernández A., Planchenault T., Baleux F., Staropoli I., Le-Barillec K., Leduc D., Delaunay T., Lazarini F., Virelizier J. L., Chignard M., Pidard D., Arenzana-Seisdedos F., Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. Journal of Biological Chemistry 2002 277 18 15677 15689 2-s2.0-0037013221 10.1074/jbc.M111388200 (Pubitemid 34967841)
65. Damås J. K., Waehre T., Yndestad A., Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002 106 1 36 42 10.1161/01.CIR. 0000020001.09990.90 (Pubitemid 34747439)
66. Smith D. F., Galkina E., Ley K., Huo Y., GRO family chemokines are specialized for monocyte arrest from flow. American Journal of Physiology-Heart and Circulatory Physiology 2005 289 5 H1976 H1984 2-s2.0-27144545775 10.1152/ajpheart.00153.2005 (Pubitemid 41507347)
67. Power C. A., Furness R. B., Brawand C., Wells T. N. C., Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Gene 1994 151 1-2 333 334 2-s2.0-0028567739 10.1016/0378-1119(94) 90682-3
68. Yilmaz A., Lipfert B., Cicha I., Schubert K., Klein M., Raithel D., Daniel W. G., Garlichs C. D., Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques. Experimental and Molecular Pathology 2007 82 3 245 255 2-s2.0-34247586138 10.1016/j.yexmp.2006.10.008 (Pubitemid 46686659)
69. Eid R. E., Rao D. A., Zhou J., Lo S. F. L., Ranjbaran H., Gallo A., Sokol S. I., Pfau S., Pober J. S., Tellides G., Interleukin-17 and interferon- γ are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009 119 10 1424 1432 2-s2.0-64549126102 10.1161/CIRCULATIONAHA.108.827618
70. Liuzzo G., Vallejo A. N., Kopecky S. L., Frye R. L., Holmes D. R., Goronzy J. J., Weyand C. M., Molecular fingerprint of interferon- γ signaling in unstable angina. Circulation 2001 103 11 1509 1514 2-s2.0-0035916880 (Pubitemid 32226257)
71. Nagata T., Kai H., Shibata R., Koga M., Yoshimura A., Imaizumi T., Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 588 593 2-s2.0-0037389156 10.1161/01.ATV.0000060891.31516.24 (Pubitemid 36438070)
72. Michalak M., Corbett E. F., Mesaeli N., Nakamura K., Opas M., Calreticulin: one protein, one gene, many functions. Biochemical Journal 1999 344, part 2 281 292 2-s2.0-0033460216 10.1042/0264-6021:3440281 (Pubitemid 30011581)
73. Lim S., Chang W., Lee B. K., Song H., Hong J. H., Lee S., Son B. W., Kim H. J., Cha M. J., Jang Y., Chung N., Choi S. Y., Hwang K. C., Enhanced calreticulin expression promotes calcium-dependent apoptosis in postnatal cardiomyocytes. Molecules and Cells 2008 25 3 390 396 2-s2.0-46149094254
74. Liu X., Wu X., Cai L., Sun S., Calreticulin downregulation is associated with FGF-2-induced angiogenesis through calcineurin pathway in ischemic myocardium. Shock 2008 29 1 140 148 2-s2.0-37549053602 10.1097/shk. 0b013e318123e822
75. Gardai S. J., Xiao Y. Q., Dickinson M., Nick J. A., Voelker D. R., Greene K. E., Henson P. M., By binding SIRP α or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003 115 1 13 23 2-s2.0-0141918823 10.1016/S0092-8674(03) 00758-X (Pubitemid 37255314)
76. Nepom G. T., Erlich H., MHC class-II molecules and autoimmunity. Annual Review of Immunology 1991 9 493 525 2-s2.0-0025817428
77. de Palma R., del Galdo F., Abbate G., Chiariello M., Calabró R., Forte L., Cimmino G., Papa M. F., Russo M. G., Ambrosio G., Giombolini C., Tritto I., Notaristefano S., Berrino L., Rossi F., Golino P., Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque evidence for a local, intracoronary immunologic mechanism. Circulation 2006 113 5 640 646 2-s2.0-33644857973 10.1161/CIRCULATIONAHA.105.537712
78. Boyton R. J., Altmann D. M., Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clinical and Experimental Immunology 2007 149 1 1 8 2-s2.0-34250158132 10.1111/j.1365-2249.2007.03424.x (Pubitemid 46897116)
79. Whitman S. C., Rateri D. L., Szilvassy S. J., Yokoyama W., Daugherty A., Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 6 1049 1054 2-s2.0-2942516034 10.1161/01.ATV. 0000124923.95545.2c (Pubitemid 38737830)
80. Vaseva A. V., Moll U. M., The mitochondrial p53 pathway. Biochimica et Biophysica Acta 2009 1787 5 414 420 2-s2.0-67349086630 10.1016/j.bbabio.2008.10. 005
81. Yuan X. M., Osman E., Miah S., Zadeh S. N. M., Xu L., Forssell C., Li W., P53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations. Atherosclerosis 2010 210 2 392 399 2-s2.0-77953229649 10.1016/j.atherosclerosis.2009.11.048
82. Connell-Crowley L., Harper J. W., Goodrich D. W., Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Molecular Biology of the Cell 1997 8 2 287 301 2-s2.0-0031019197 (Pubitemid 27097944)
83. Gordon D., Reidy M. A., Benditt E. P., Schwartz S. M., Cell proliferation in human coronary arteries. Proceedings of the National Academy of Sciences of the United States of America 1990 87 12 4600 4604 2-s2.0-0025294867 10.1073/pnas.87.12.4600 (Pubitemid 20204150)
84. Zettler M. E., Prociuk M. A., Austria J. A., Massaeli H., Zhong G., Pierce G. N., OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. American Journal of Physiology-Heart and Circulatory Physiology 2003 284 2 H644 H653 2-s2.0-0037304753 (Pubitemid 36142893)
85. Passer B. J., Nancy-Portebois V., Amzallag N., Prieur S., Cans C., De Climens A. R., Fiucci G., Bouvard V., Tuynder M., Susini L., Morchoisne S., Crible V., Lespagnol A., Dausset J., Oren M., Amson R., Telerman A., The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2284 2289 2-s2.0-0037418216 10.1073/pnas.0530298100 (Pubitemid 36297491)
86. Gupta R. K., Tripathi R., Naidu B. J., Srinivas U. K., Shashidhara L. S., Cell cycle regulation by the pro-apoptotic gene scotin. Cell Cycle 2008 7 15 2401 2408 2-s2.0-48849093490
87. Maiuri M. C., Malik S. A., Morselli E., Kepp O., Criollo A., Mouchel P. L., Carnuccio R., Kroemer G., Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 2009 8 10 1571 1576 2-s2.0-66849111716
88. Ma X. J., Yin H. J., Chen K. J., Differential gene expression profiles in coronary heart disease patients of blood stasis syndrome in traditional Chinese medicine and clinical role of target gene. Chinese Journal of Integrative Medicine 2009 15 2 101 106 2-s2.0-65349092870 10.1007/s11655-009-0101-4
89. Fichtlscherer S., de Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C. W., Röxe T., Müller-Ardogan M., Bonauer A., Zeiher A. M., Dimmeler S., Circulating microRNAs in patients with coronary artery disease. Circulation Research 2010 107 5 677 684 2-s2.0-77957028990 10.1161/CIRCRESAHA.109.215566
90. Taurino C., Miller W. H., McBride M. W., Gene expression profiling in whole blood of patients with coronary artery disease. Clinical Science 2010 119, part 8 335 343
91. Hoekstra M., van der Lans C. A. C., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., van Berkel T. J. C., Biessen E. A. L., The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochemical and Biophysical Research Communications 2010 394 3 792 797 2-s2.0-77950518455 10.1016/j.bbrc.2010.03.075
92. Wang S., Aurora A. B., Johnson B. A., Qi X., McAnally J., Hill J. A., Richardson J. A., Bassel-Duby R., Olson E. N., The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell 2008 15 2 261 271 2-s2.0-48549106378 10.1016/j.devcel.2008.07.002
93. Chen Y., Gorski D. H., Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008 111 3 1217 1226 2-s2.0-38949193234 10.1182/blood-2007-07-104133 (Pubitemid 351213403)
94. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X., Sun Q., Wang K., Ba Y., Wang Q., Wang D., Yang J., Liu P., Xu T., Yan Q., Zhang J., Zen K., Zhang C. Y., Secreted monocytic miR-150 enhances targeted endothelial cell migration. Molecular Cell 2010 39 1 133 144 2-s2.0-77954257796 10.1016/j.molcel.2010.06.010
95. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research 2009 104 4 476 486 2-s2.0-61949252089 10.1161/CIRCRESAHA.108.185363
96. Bonauer A., Carmona G., Iwasaki M., MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009 324 5935 1710 1713 10.1126/science.1174381
97. Snowden A. W., Anderson L. A., Webster G. A., Perkins N. D., A novel transcriptional repression domain mediates p21WAF1/CIP1 induction of p300 transactivation. Molecular and Cellular Biology 2000 20 8 2676 2686 2-s2.0-0034069878 10.1128/MCB.20.8.2676-2686.2000 (Pubitemid 30183486)
98. Zhang H. S., Gavin M., Dahiya A., Postigo A. A., Ma D., Luo R. X., Harbour J. W., Dean D. C., Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and RB-hSWI/SNF. Cell 2000 101 1 79 89 2-s2.0-0034737290
99. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R. A., Dynlacht B. D., E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes and Development 2002 16 2 245 256 2-s2.0-0037080483 10.1101/gad.949802 (Pubitemid 34075816)
100. Li L., Iwamoto Y., Berezovskaya A., Boussiotis V. A., A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nature Immunology 2006 7 11 1157 1165 2-s2.0-33750123428 10.1038/ni1398 (Pubitemid 44594311)
101. Amati B., Littlewood T. D., Evan G. I., Land H., The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. The EMBO Journal 1993 12 13 5083 5087 2-s2.0-0027364326 (Pubitemid 23358497)
102. Kim A. H., Khursigara G., Sun X., Franke T. F., Chao M. V., Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Molecular and Cellular Biology 2001 21 3 893 901 2-s2.0-0035133227 10.1128/MCB.21.3.893-901.2001 (Pubitemid 32104737)
103. Issbrücker K., Marti H. H., Hippenstiel S., p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. The FASEB Journal 2003 17 2 262 264
104. Ackah E., Yu J., Zoellner S., Iwakiri Y., Skurk C., Shibata R., Ouchi N., Easton R. M., Galasso G., Birnbaum M. J., Walsh K., Sessa W. C., Akt1/protein kinase B α is critical for ischemic and VEGF-mediated angiogenesis. Journal of Clinical Investigation 2005 115 8 2119 2127 2-s2.0-23644446866 10.1172/JCI24726 (Pubitemid 41134153)
105. Eliceiri B. P., Paul R., Schwartzberg P. L., Hood J. D., Leng J., Cheresh D. A., Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Molecular Cell 1999 4 6 915 924 2-s2.0-0033393771 (Pubitemid 30054898)
106. Taganov K. D., Boldin M. P., Chang K. J., Baltimore D., NF- B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 2006 103 33 12481 12486 2-s2.0-33747608638 10.1073/pnas.0605298103 (Pubitemid 44267285)
107. O'Neill L. A., Sheedy F. J., McCoy C. E., MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nature Reviews Immunology 2011 11 3 163 175 2-s2.0-79952186298 10.1038/nri2957
108. Bhaumik D., Scott G. K., Schokrpur S., Patil C. K., Orjalo A. V., Rodier F., Lithgow G. J., Campisi J., MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging 2009 1 4 402 411 2-s2.0-67649318940
109. Recchiuti A., Krishnamoorthy S., Fredman G., Chiang N., Serhan C. N., MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. The FASEB Journal 2011 25 2 544 560 2-s2.0-79551625082 10.1096/fj.10-169599
110. Hulsmans M., van Dooren E., Mathieu C., Holvoet P., Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PloS One 2012 7 2 e32794
111. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., Vatner D. E., Vatner S. F., Abdellatif M., Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research 2009 104 7 879 886 2-s2.0-65249185780 10.1161/CIRCRESAHA.108.193102